OTO-313 in Subjects With Subjective Tinnitus
Public ClinicalTrials.gov record NCT03918109. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Phase 1/2 Study of OTO-313 Given as a Single Intratympanic Injection in Subjects With Subjective Tinnitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety, tolerability, plasma pharmacokinetics (PK), and exploratory efficacy of OTO-313 administered as an intratympanic injection for the treatment of subjective tinnitus.
Study identification
- NCT ID
- NCT03918109
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 43 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 4, 2019 (Actual)
- Primary completion
- May 29, 2020 (Actual)
- Completion
- May 29, 2020 (Actual)
- Last update posted
- Dec 23, 2022
2019 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| House Clinic | Los Angeles | California | 90057 | — |
| California Head & Neck Specialists | San Diego | California | 92121 | — |
| Colorado ENT and Allergy | Colorado Springs | Colorado | 80909 | — |
| Silverstein Institute/Ear Research Foundation | Sarasota | Florida | 34239 | — |
| ChicagoENT | Chicago | Illinois | 60657 | — |
| Advanced ENT and Allergy | Louisville | Kentucky | 40207 | — |
| Tandem Clinical Research, LLC | Marrero | Louisiana | 70072 | — |
| Summit Medical Group | Berkeley Heights | New Jersey | 10882 | — |
| Dent Neurosciences Research Center | Amherst | New York | 14226 | — |
| Northwell Health, Hearing & Speech Center | New Hyde Park | New York | 11042 | — |
| Northwell Health at ENT and Allergy Associates | White Plains | New York | 10605 | — |
| Charlotte Eye Ear Nose & Throat Associates | Charlotte | North Carolina | 28210 | — |
| Piedmont Ear, Nose, and Throat Associates | Winston-Salem | North Carolina | 27103 | — |
| Worldwide Clinical Trials | San Antonio | Texas | 78217 | — |
| Chrysalis Clinical Research | St. George | Utah | 84790 | — |
| WVU Medicine | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03918109, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2022 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03918109 live on ClinicalTrials.gov.